Literature DB >> 33167721

SARS-CoV-2 in multiple myeloma: initial observation and management.

Elisabet E Manasanch1, Victor Mulanovich2, Joanna-Grace Manzano2, Maria Susan Gaeta3, Melody Becnel1, Gregory P Kaufman1, Hans C Lee1, Behrang Amini4, Sheeba K Thomas1, Swaminathan P Iyer1, Donna M Weber1, Zuzana Berkova1, Christopher R Flowers1, Robert Z Orlowski1, Krina K Patel1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33167721      PMCID： PMC8092112          DOI： 10.1080/10428194.2020.1780588

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

1.  Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Authors:  Cecilie Blimark; Erik Holmberg; Ulf-Henrik Mellqvist; Ola Landgren; Magnus Björkholm; Malin Hultcrantz; Christian Kjellander; Ingemar Turesson; Sigurdur Y Kristinsson
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

2.  COVID-19 and African Americans.

Authors:  Clyde W Yancy
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

3.  Macrolide treatment for COVID-19: Will this be the way forward?

Authors:  Masashi Ohe; Haruki Shida; Satoshi Jodo; Yoshihiro Kusunoki; Masahide Seki; Ken Furuya; Houman Goudarzi
Journal:  Biosci Trends       Date:  2020-04-05       Impact factor: 2.400

Review 4.  Immunodeficiency and immunotherapy in multiple myeloma.

Authors:  Guy Pratt; Oliver Goodyear; Paul Moss
Journal:  Br J Haematol       Date:  2007-09       Impact factor: 6.998

5.  Tocilizumab treatment in COVID-19: A single center experience.

Authors:  Pan Luo; Yi Liu; Lin Qiu; Xiulan Liu; Dong Liu; Juan Li
Journal:  J Med Virol       Date:  2020-04-15       Impact factor: 2.327

6.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

7.  Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.

Authors:  Theresa L Wampler Muskardin
Journal:  ACR Open Rheumatol       Date:  2020-04-08

8.  Upheaval in cancer care during the COVID-19 outbreak.

Authors:  Omolola Salako; Kehinde Okunade; Matthew Allsop; Muhammedu Habeebu; Mariam Toye; Glory Oluyede; Gabriel Fagbenro; Babatunde Salako
Journal:  Ecancermedicalscience       Date:  2020-04-01

9.  First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.

Authors:  Xuhan Zhang; Kaidi Song; Fei Tong; Mingming Fei; Hui Guo; Zhaohui Lu; Jinquan Wang; Changcheng Zheng
Journal:  Blood Adv       Date:  2020-04-14

10.  Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome.

Authors:  Luke Adam Monteagudo; Aaron Boothby; Elie Gertner
Journal:  ACR Open Rheumatol       Date:  2020-04-21
  10 in total
  1 in total

1.  COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia.

Authors:  Quinto Gesiotto; Asima Cheema; Kishan Avaiya; Bijal Shah; John Greene
Journal:  Cureus       Date:  2021-05-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.